Protein kinase C activation by phorbol eater increases in vitro invasion through regulation of matrix metalloproteinases/tissue inhibitors of metalloproteinases system in D54 human glioblastoma cells

被引:54
作者
Park, MJ
Park, IC
Hur, JH
Rhee, CH
Choe, TB
Yi, DH
Hong, SI
Lee, SH
机构
[1] Korea Canc Ctr Hosp, Cell Biol Lab, Nowon Ku, Seoul 139240, South Korea
[2] Korea Canc Ctr Hosp, Dept Neurosurg, Seoul 139240, South Korea
[3] Konkuk Hosp, Dept Microbiol Engn, Seoul, South Korea
关键词
invasion; matrix metalloproteinases; protein kinase C; tissue inhibitors of metalloproteinases; glioblastoma;
D O I
10.1016/S0304-3940(00)01358-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
To elucidate possible mechanisms of phorbol 12-myristate 13-acetate (PMA) induced in vitro invasiveness of glioblastoma cells, we examined expression levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 using Western blotting and gelatin zymography assay, and found that PMA induced the secretion of MMP-9, activated MMP-2 proenzyme to fully active form of 59 kDa, down-regulated the TIMP-1 and TIMP-2 secretion, and increased MT1-MMP on the cell surface. However, PKC inhibitor Go 6983 reversed all of these effects brought about by PMA. We, therefore, conclude the activation of PKC by PMA in these cells plays a critical role in the regulation of MMPs/TIMPs system, which has a major role in tumor invasion and metastasis. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:201 / 204
页数:4
相关论文
共 18 条
[1]  
AZZAM HS, 1992, CANCER RES, V52, P4540
[2]   Matrix metalloproteinases as stromal effectors of human carcinoma progression: Therapeutic implications [J].
Basset, P ;
Okada, A ;
Chenard, MP ;
Kannan, R ;
Stoll, I ;
Anglard, P ;
Bellocq, JP ;
Rio, MC .
MATRIX BIOLOGY, 1997, 15 (8-9) :535-541
[3]   MATRIX METALLOPROTEINASES - A REVIEW [J].
BIRKEDALHANSEN, H ;
MOORE, WGI ;
BODDEN, MK ;
WINDSOR, LJ ;
BIRKEDALHANSEN, B ;
DECARLO, A ;
ENGLER, JA .
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 1993, 4 (02) :197-250
[4]  
DAVIES B, 1993, CANCER RES, V53, P5365
[5]  
EMONARD HP, 1992, CANCER RES, V52, P5845
[6]  
Foda HD, 1996, LAB INVEST, V74, P538
[7]   Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes [J].
Gschwendt, M ;
Dieterich, S ;
Rennecke, J ;
Kittstein, W ;
Mueller, HJ ;
Johannes, FJ .
FEBS LETTERS, 1996, 392 (02) :77-80
[8]  
Heppner KJ, 1996, AM J PATHOL, V149, P273
[9]   Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation [J].
Johnsen, M ;
Lund, LR ;
Romer, J ;
Almholt, K ;
Dano, K .
CURRENT OPINION IN CELL BIOLOGY, 1998, 10 (05) :667-671
[10]  
LIOTTA LA, 1992, BIOASSAYS, V14, P455